Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Heron Therapeutics, Inc.
About HRTX
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutics that improve medical care. Its acute care product portfolio includes ZYNRELEF, APONVIE, CINVANTI, and SUSTOL. ZYNRELEF is a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low-dose of the nonsteroidal anti-inflammatory drug meloxicam. APONVIE is the intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist indicated for postoperative nausea and vomiting in adults. CINVANTI is an IV formulation of aprepitant, a substance NK1 receptor antagonist. SUSTOL is the first extended-release 5-HT3 receptor antagonist approved for the prevention of acute and delayed nausea and vomiting associated with both MEC and anthracycline and cyclophosphamide combination chemotherapy regimens.
Find out what a historical investment in Heron Therapeutics, Inc. would be worth today using our HRTX stock calculator.
Market Capitalisation
$160.53M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.12M
High today
$0.86
Low today
$0.83
Open price
$0.86
52-week high
$2.30
52-week low
$0.74
Ready to start your investing journey with Stake?
Open an accountHow do I buy HRTX shares in Australia?
Buying HRTX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Heron Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in HRTX
What is the ticker symbol of Heron Therapeutics, Inc.?
The ticker symbol for Heron Therapeutics, Inc. is HRTX.
How much is one share of HRTX?
One share of HRTX is valued at $0.85 as of 20 May 2026.
What is the market capitalisation of Heron Therapeutics, Inc. HRTX?
As of 20 May 2026 Heron Therapeutics, Inc. has a market cap of $160.53M.
What is the 52-week high for Heron Therapeutics, Inc. stock?
The Heron Therapeutics, Inc. 52-week high stock price is $2.30.
What is the 52-week low for Heron Therapeutics, Inc. stock?
The Heron Therapeutics, Inc. 52-week low stock price is $0.74.
Can I buy HRTX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy HRTX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in HRTX on Stake
- Buy HRTX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of HRTX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
HRTX related stocks